Cho Michael Jeffrey, Lo Agnes S Y, Mao Xuming, Nagler Arielle R, Ellebrecht Christoph T, Mukherjee Eric M, Hammers Christoph M, Choi Eun-Jung, Sharma Preety M, Uduman Mohamed, Li Hong, Rux Ann H, Farber Sara A, Rubin Courtney B, Kleinstein Steven H, Sachais Bruce S, Posner Marshall R, Cavacini Lisa A, Payne Aimee S
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Nat Commun. 2014 Jun 19;5:4167. doi: 10.1038/ncomms5167.
Pemphigus vulgaris (PV) is a potentially fatal blistering disease caused by autoantibodies (autoAbs) against desmoglein 3 (Dsg3). Here, we clone anti-Dsg3 antibodies (Abs) from four PV patients and identify pathogenic VH1-46 autoAbs from all four patients. Unexpectedly, VH1-46 autoAbs had relatively few replacement mutations. We reverted antibody somatic mutations to their germline sequences to determine the requirement of mutations for autoreactivity. Three of five VH1-46 germline-reverted Abs maintain Dsg3 binding, compared with zero of five non-VH1-46 germline-reverted Abs. Site-directed mutagenesis of VH1-46 Abs demonstrates that acidic amino-acid residues introduced by somatic mutation or heavy chain VDJ recombination are necessary and sufficient for Dsg3 binding. Our data suggest that VH1-46 autoantibody gene usage is commonly found in PV because VH1-46 Abs require few to no mutations to acquire Dsg3 autoreactivity, which may favour their early selection. Common VH gene usage indicates common humoral immune responses, even among unrelated patients.
寻常型天疱疮(PV)是一种由针对桥粒芯糖蛋白3(Dsg3)的自身抗体(autoAbs)引起的潜在致命性水疱病。在此,我们从四名PV患者中克隆了抗Dsg3抗体(Abs),并从所有四名患者中鉴定出致病性VH1-46自身抗体。出乎意料的是,VH1-46自身抗体的替换突变相对较少。我们将抗体体细胞突变回复到其种系序列,以确定自身反应性对突变的需求。与五个非VH1-46种系回复抗体中零个相比,五个VH1-46种系回复抗体中有三个保持Dsg3结合。VH1-46抗体的定点诱变表明,体细胞突变或重链VDJ重组引入的酸性氨基酸残基对于Dsg3结合是必要且充分的。我们的数据表明,VH1-46自身抗体基因的使用在PV中很常见,因为VH1-46抗体几乎不需要或不需要突变就能获得Dsg3自身反应性,这可能有利于它们的早期选择。常见的VH基因使用表明即使在不相关的患者中也存在共同的体液免疫反应。